These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28957756)

  • 1. Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine.
    Madden L; Bojko MJ; Farnum S; Mazhnaya A; Fomenko T; Marcus R; Barry D; Ivanchuk I; Kolomiets V; Filippovych S; Dvoryak S; Altice FL
    Int J Drug Policy; 2017 Nov; 49():48-53. PubMed ID: 28957756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine.
    Morozova O; Dvoriak S; Pykalo I; Altice FL
    Drug Alcohol Depend; 2017 Apr; 173():132-138. PubMed ID: 28242537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.
    Bojko MJ; Mazhnaya A; Marcus R; Makarenko I; Islam Z; Filippovych S; Dvoriak S; Altice FL
    J Subst Abuse Treat; 2016 Jul; 66():37-47. PubMed ID: 27211995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
    Kiriazova T; Go VF; Hershow RB; Hamilton EL; Sarasvita R; Bui Q; Lancaster KE; Dumchev K; Hoffman IF; Miller WC; Latkin CA
    Harm Reduct J; 2020 Oct; 17(1):69. PubMed ID: 32998731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.
    Farnum SO; Makarenko I; Madden L; Mazhnaya A; Marcus R; Prokhorova T; Bojko MJ; Rozanova J; Dvoriak S; Islam Z; Altice FL
    Addiction; 2021 Jan; 116(1):83-93. PubMed ID: 32428276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine.
    Makarenko I; Mazhnaya A; Marcus R; Pykalo I; Madden L; Filippovich S; Dvoriak S; Altice FL
    J Subst Abuse Treat; 2018 Apr; 87():1-8. PubMed ID: 29471921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study.
    Tan J; Altice FL; Madden LM; Zelenev A
    Lancet HIV; 2020 Feb; 7(2):e121-e128. PubMed ID: 31879250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
    Makarenko I; Mazhnaya A; Polonsky M; Marcus R; Bojko MJ; Filippovych S; Springer S; Dvoriak S; Altice FL
    Drug Alcohol Depend; 2016 Aug; 165():213-20. PubMed ID: 27370527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis.
    Morozova O; Crawford FW; Cohen T; Paltiel AD; Altice FL
    Addiction; 2020 Mar; 115(3):437-450. PubMed ID: 31478285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful transfer of stable patients on opioid agonist therapies from specialty addiction treatment to primary care settings in Ukraine: A pilot study.
    Meteliuk A; Galvez S; Fomenko T; Kalandiia H; Iaryi V; Farnum SO; Islam Z; Altice FL; Madden LM
    J Subst Abuse Treat; 2022 Mar; 134():108619. PubMed ID: 34579978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.
    Mazhnaya A; Marcus R; Bojko MJ; Zelenev A; Makarenko I; Pykalo I; Filippovych S; Dvoriak S; Altice FL
    J Acquir Immune Defic Syndr; 2018 Nov; 79(3):288-295. PubMed ID: 30312275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of emergency guidance to the COVID-19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine.
    Ivasiy R; Madden LM; Meteliuk A; Machavariani E; Ahmad B; Zelenev A; Desai MM; Bromberg DJ; Polonsky M; Galvez de Leon SJ; Farnum SO; Islam Z; Altice FL
    Addiction; 2024 Sep; 119(9):1585-1596. PubMed ID: 38807448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
    Makarenko I; Mazhnaya A; Marcus R; Bojko MJ; Madden L; Filippovich S; Dvoriak S; Altice FL
    Int J Drug Policy; 2017 Jul; 45():56-63. PubMed ID: 28628853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.
    Geddes L; Iversen J; Wand H; Maher L
    Addiction; 2021 Mar; 116(3):525-535. PubMed ID: 32557931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid treatment in Ukraine risks losing momentum.
    Bull World Health Organ; 2013 Feb; 91(2):87-8. PubMed ID: 23554519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine.
    Zelenev A; Shea P; Mazhnaya A; Rozanova J; Madden L; Marcus R; Altice FL
    Drug Alcohol Depend; 2018 Sep; 190():82-88. PubMed ID: 29990648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine.
    Meteliuk A; Galvez de Leon SJ; Madden LM; Pykalo I; Fomenko T; Filippovych M; Farnum SO; Dvoryak S; Islam ZM; Altice FL
    J Subst Abuse Treat; 2021 Feb; 121():108164. PubMed ID: 33191004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustainability of opioid agonist therapy programmes in Belarus, the Republic of Moldova, Tajikistan and Ukraine in the context of transition from Global Fund support during 2020-2023.
    Stuikyte R; Varentsov I; Malikov N; Dvoriak S; Filippovych M; Latypov A; Kralko A; Iatco A; Cook C
    Harm Reduct J; 2024 Oct; 21(1):183. PubMed ID: 39407276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-examining provider perceptions of best pre-war practices: what elements can help opiate agonist therapy programs in Ukraine successfully survive the crisis?
    Dellamura P; Meteliuk A; Fomenko T; Rozanova J
    Front Public Health; 2023; 11():1259488. PubMed ID: 38239802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.